Falk Thiel
University of Erlangen-Nuremberg
91 Papers
724 Citations
Falk Thiel is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Medicine & Ovarian cancer. The author has an hindex of 25, co-authored 89 publications. Previous affiliations of Falk Thiel include University of Duisburg-Essen.
Chat about Author
Papers
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
Ellen L. Goode,Georgia Chenevix-Trench,Honglin Song,Susan J. Ramus,Maria Notaridou,Kate Lawrenson,Martin Widschwendter,Robert A. Vierkant,Melissa C. Larson,Susanne K. Kjaer,Michael J. Birrer,Andrew Berchuck,Joellen M. Schildkraut,Ian Tomlinson,Lambertus A. Kiemeney,Linda S. Cook,Linda S. Cook,Jacek Gronwald,Montserrat Garcia-Closas,Martin Gore,Ian G. Campbell,Ian G. Campbell,Alice S. Whittemore,Rebecca Sutphen,Catherine M. Phelan,Hoda Anton-Culver,Celeste Leigh Pearce,Diether Lambrechts,Mary Anne Rossing,Jenny Chang-Claude,Kirsten B. Moysich,Marc T. Goodman,Thilo Dörk,Heli Nevanlinna,Roberta B. Ness,Thorunn Rafnar,Claus Høgdall,Estrid Høgdall,Brooke L. Fridley,Julie M. Cunningham,Weiva Sieh,Valerie McGuire,Andrew K. Godwin,Daniel W. Cramer,Dena G. Hernandez,Douglas A. Levine,Karen H. Lu,Edwin S. Iversen,Rachel T. Palmieri,Richard S. Houlston,Anne M. van Altena,Katja K.H. Aben,Leon F.A.G. Massuger,Angela Brooks-Wilson,Angela Brooks-Wilson,Linda E. Kelemen,Nhu D. Le,Anna Jakubowska,Jan Lubinski,Krzysztof Mędrek,Anne Stafford,Douglas F. Easton,Jonathan Tyrer,Kelly L. Bolton,Patricia Harrington,Diana Eccles,Ann Chen,Ashley D. Molina,Barbara N Davila,Hector Arango,Ya-Yu Tsai,Zhihua Chen,Harvey A. Risch,John R. McLaughlin,Steven A. Narod,Argyrios Ziogas,Wendy Brewster,Aleksandra Gentry-Maharaj,Usha Menon,Anna H. Wu,Daniel O. Stram,Malcolm C. Pike,Jonathan Beesley,Penelope M. Webb,Penelope M. Webb,Xiaoqing Chen,Arif B. Ekici,Falk Thiel,Matthias W. Beckmann,Hannah P. Yang,Nicolas Wentzensen,Jolanta Lissowska,Peter A. Fasching,Evelyn Despierre,Frédéric Amant,Ignace Vergote,Jennifer A. Doherty,Rebecca Hein,Shan Wang-Gohrke,Galina Lurie,Michael E. Carney,Pamela J. Thompson,I. Runnebaum,Peter Hillemanns,Matthias Dürst,Natalia Antonenkova,Natalia Bogdanova,Arto Leminen,Ralf Bützow,Tuomas Heikkinen,Kari Stefansson,Patrick Sulem,Søren Besenbacher,Thomas A. Sellers,Simon A. Gayther,Paul D.P. Pharoah +115 more
TL;DR: Nine additional candidate loci are reported on and analysis of HOXD1, MYC, TIPARP and SKAP1 at these loci and of BNC2 at 9p22 supports a functional role for these genes in ovarian cancer development.
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
Honglin Song,Susan J. Ramus,Jonathan Tyrer,Kelly L. Bolton,Kelly L. Bolton,Aleksandra Gentry-Maharaj,Eva Wozniak,Hoda Anton-Culver,Jenny Chang-Claude,Daniel W. Cramer,Richard A. DiCioccio,Thilo Dörk,Ellen L. Goode,Marc T. Goodman,Joellen M. Schildkraut,Thomas A. Sellers,Laura Baglietto,Laura Baglietto,Matthias W. Beckmann,Jonathan Beesley,Jan Blaakær,Michael E. Carney,Stephen J. Chanock,Zhihua Chen,Julie M. Cunningham,Ed Dicks,Jennifer A. Doherty,Matthias Dürst,Arif B. Ekici,David Fenstermacher,Brooke L. Fridley,Graham G. Giles,Graham G. Giles,Martin Gore,Immaculata De Vivo,Peter Hillemanns,Claus Høgdall,Estrid Høgdall,Edwin S. Iversen,Ian Jacobs,Anna Jakubowska,Dong Li,Jolanta Lissowska,Jan Lubinski,Galina Lurie,Valerie McGuire,John R. McLaughlin,Krzysztof Mȩdrek,Patricia G. Moorman,Kirsten B. Moysich,Steven A. Narod,Catherine M. Phelan,Carole Pye,Harvey A. Risch,Ingo B. Runnebaum,Gianluca Severi,Gianluca Severi,Melissa C. Southey,Daniel O. Stram,Falk Thiel,Kathryn L. Terry,Ya Yu Tsai,Shelley S. Tworoger,David Van Den Berg,Robert A. Vierkant,Shan Wang-Gohrke,Penelope M. Webb,Lynne R. Wilkens,Anna H. Wu,Hannah P. Yang,Wendy Brewster,Argyrios Ziogas,Richard S. Houlston,Ian Tomlinson,Alice S. Whittemore,Mary Anne Rossing,Bruce A.J. Ponder,Celeste Leigh Pearce,Roberta B. Ness,Usha Menon,Susanne K. Kjaer,Jacek Gronwald,Montserrat Garcia-Closas,Peter A. Fasching,Peter A. Fasching,Douglas F. Easton,Georgia Chenevix-Trench,Andrew Berchuck,Paul D.P. Pharoah,Simon A. Gayther +89 more
TL;DR: A genome-wide association study to identify common ovarian cancer susceptibility alleles was performed, identifying 12 SNPs at 9p22 associated with disease risk and the most significant SNP was genotyped in 2,670 ovarian cancer cases and 4,668 controls.
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
Kelly L. Bolton,Kelly L. Bolton,Jonathan Tyrer,Honglin Song,Susan J. Ramus,Maria Notaridou,Chris Jones,Tanya Sher,Aleksandra Gentry-Maharaj,Eva Wozniak,Ya-Yu Tsai,Joanne B. Weidhaas,Daniel Paik,David Van Den Berg,Daniel O. Stram,Celeste Leigh Pearce,Anna H. Wu,Wendy R. Brewster,Hoda Anton-Culver,Argyrios Ziogas,Steven A. Narod,Douglas A. Levine,Stanley B. Kaye,Robert S. Brown,James Paul,James M. Flanagan,Weiva Sieh,Valerie McGuire,Alice S. Whittemore,Ian G. Campbell,Martin Gore,Jolanta Lissowska,Hanna P. Yang,Krzysztof Mędrek,Jacek Gronwald,Jan Lubinski,Anna Jakubowska,Nhu D. Le,Linda S. Cook,Linda S. Cook,Linda E. Kelemen,Angela Brook-Wilson,Angela Brook-Wilson,Leon F.A.G. Massuger,Lambertus A. Kiemeney,Katja K.H. Aben,Anne M. van Altena,Richard S. Houlston,Ian Tomlinson,Rachel T. Palmieri,Patricia G. Moorman,Joellen M. Schildkraut,Edwin S. Iversen,Catherine M. Phelan,Robert A. Vierkant,Julie M. Cunningham,Ellen L. Goode,Brooke L. Fridley,Susan Kruger-Kjaer,Jan Blaeker,Estrid Høgdall,Claus Høgdall,Jenny Gross,Beth Y. Karlan,Roberta B. Ness,Robert P. Edwards,Kunle Odunsi,Kirsten B. Moyisch,Julie A. Baker,Francesmary Modugno,Tuomas Heikkinenen,Ralf Bützow,Heli Nevanlinna,Arto Leminen,Natalia Bogdanova,Natalia Antonenkova,Thilo Doerk,Peter Hillemanns,Matthias Dürst,Ingo B. Runnebaum,Pamela J. Thompson,Michael E. Carney,Marc T. Goodman,Galina Lurie,Shan Wang-Gohrke,Rebecca Hein,Jenny Chang-Claude,Mary Anne Rossing,Kara L. Cushing-Haugen,Jennifer A. Doherty,Chu Chen,Thorunn Rafnar,Søren Besenbacher,Patrick Sulem,Kari Stefansson,Michael J. Birrer,Kathryn L. Terry,Dena G. Hernandez,Daniel W. Cramer,Ignace Vergote,Frédéric Amant,Diether Lambrechts,Evelyn Despierre,Peter A. Fasching,Matthias W. Beckmann,Falk Thiel,Arif B. Ekici,Xiaoqing Chen,Sharon E. Johnatty,Penelope M. Webb,Jonathan Beesley,Stephen J. Chanock,Montserrat Garcia-Closas,T A Sellers,Douglas F. Easton,Andrew Berchuck,Georgia Chenevix-Trench,Paul D.P. Pharoah,Simon A. Gayther +118 more
TL;DR: In this article, a three-phase genome-wide association study of EOC survival in 8,951 individuals with EOC (cases) with available survival time data and a parallel association analysis of susceptibility showed evidence of association with survival.
Adjuvant Therapy in Lymph Node–Positive Vulvar Cancer: The AGO-CaRE-1 Study
Sven Mahner,Julia Kathrin Jueckstock,Felix Hilpert,Petra Neuser,Philipp Harter,Nikolaus de Gregorio,Annette Hasenburg,Jalid Sehouli,Annika Habermann,Peter Hillemanns,Sophie Fuerst,Hans-Georg Strauss,Klaus Baumann,Falk Thiel,Alexander Mustea,Werner Meier,Andreas du Bois,Lis-Femke Griebel,Linn Woelber +18 more
TL;DR: This large multicenter study in vulvar cancer observed that adjuvant radiotherapy was associated with improved prognosis in node-positive patients and will hopefully help to overcome concerns regarding adjUvant treatment, however, outcome after adjuant radiotherapy remains poor compared with node-negative patients.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial
Jacobus Pfisterer,Catherine M Shannon,Klaus Baumann,Joern Rau,Philipp Harter,Florence Joly,Jalid Sehouli,Ulrich Canzler,Barbara Schmalfeldt,Barbara Schmalfeldt,Andrew Dean,Alexander Hein,Alain G. Zeimet,Lars Hanker,Thierry Petit,Frederik Marmé,Ahmed El-Balat,Rosalind Glasspool,Nikolaus de Gregorio,Sven Mahner,Sven Mahner,Tarek M Meniawy,Tjoung-Won Park-Simon,Marie-Ange Mouret-Reynier,Cristina Costan,Werner Meier,Alexander Reinthaller,Jeffrey C Goh,Tifenn Lharidon,Sally Baron Hay,Stefan Kommoss,Andreas du Bois,Jean-Emmanuel Kurtz,Sven Ackermann,Christoph Anthuber,Mustafa Aydogdu,Angelika Baldauf,Wolfgang Bauer,Dirk Behringer,Antje Belau,Alexandra Bender,C Brucker,Alexander Burges,Trygve Daabach,Dominik Denschlag,Mustafa Deryal,Steffen Dörfel,Juliane Ebert,Tanja Fehm,Susanne Maria Feidicker,Gabriele Feisel-Schwickardi,Ricardo Felberbaum,Matthias Frank,Gerhard Gebauer,Bernd Gerber,Axel Gerhardt,Andrea Grafe,Martin Griesshammer,Eva-Maria Grischke,Isolde Gröll,Martina Gropp-Meier,Dietrich Hager,Volker Hanf,Carla Verena Hannig,Peer Hantschmann,Tanja Hauzenberger,Uwe Herwig,Martin Heubner,Carsten Hielscher,Felix Hilpert,Thomas Hitschold,Manfred Hofmann,Christian Jackisch,Wolfgang Janni,Ludwig Kiesel,Yon-Dschun Ko,Hans-Joachim Koch,Petra Krabisch,Peter Krieger,Thomas Kubin,Thorsten Kühn,Björn Lampe,Peter Ledwon,Sabine Lemster,Benno Lex,Clemens Liebrich,Ralf Lorenz,Hans-Joachim Lück,Peter Mallmann,Wolfgang Meinerz,Götz Menke,Volker Möbus,Thomas G. Müller,Volker Müller,Tanja Neunhöffer,Angelika Ober,G. Oskay-Özcelik,Horst Ostertag,Martin Pölcher,Beate Rautenberg,Daniel Rein,Wilhelm Reiter,Andreas Rempen,Ingo B. Runnebaum,Marcus Schmidt,Sabine Schnohr,Heinz Scholz,Willibald Schröder,Eike Simon,Antje Sperfeld,Annette Steckkönig,Hans-Georg Strauß,Ronaldo Stuth,Jürgen Terhaag,Falk Thiel,Marc Thill,Oliver Tomé,Christoph Uleer,Susanne Vogel,Hermann Voß,Michael Weigel,Ulrich Winkler,Arthur Wischnik,Tobias Zeiser,Andreas Zorr,R.M. Glasspool,Emma Hudson,Rachel Jones,Judith Lafleur,Christian Marth,Edgar Petru,Yoland Antill,Mary Azer,Sally Baron-Hay,Philip Beale,Stephen Begbie,Allison Black,Karen Briscoe,Andrew Dean,Jeffrey C. Goh,Sandra Harvey,Chee Lee,Marco Matos,Tarek Meniawy,Inger Olesen,Catherine Shannon,Paul A. Vasey,Sophie Abadie-Lacourtoisie,Olivier Arsene,Sophie Barthier,Célia Becuwe-Roemer,Dominique Berton-Rigaud,Maria Cappiello-Bataller,Stéphanie Catala,Francesco Del Piano,Gael Deplanque,Raymond Despax,Nadine Dohollou,Claire Garnier-Tixidré,Julien Grenier,Emmanuel Guardiola,Anne-Claire Hardy-Bessard,Claudia Lefeuvre-Plesse,Marianne Leheurteur,Anne Lesoin,Charles-Briac Levache,Raffaele Longo,Alain Lortholary,Jérôme Meunier,Nadia Raban,Olivier Romano,Jean-Michel Vannetzel,Alain Zannetti +172 more
TL;DR: This multicentre, open-label, randomised, phase 3 trial was to compare a standard bevacizumab-containing regimen versus carboplatin-pegylated liposomal doxorubicin combined with bevacsumab for progression-free survival in recurrent ovarian cancer.